RecruitingNCT04199403

Assessment of Complication Risk Factors in a French National Cohort of Asplenic Patients


Sponsor

Poitiers University Hospital

Enrollment

6,000 participants

Start Date

Jan 9, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

Spleen could have been surgically removed for trauma, cancer, auto-immune disease, or to perform a diagnosis. Spleen could be non-functional due to radiotherapy or splenic artery embolism. These patients are at risks of infectious diseases due to encapsulated bacteria, cancer, and thromboembolism disease. The purpose of this study is to assess complications occurring in French patients without spleen and to implement new diagnostic tools for follow-up.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with asplenia. The study is currently recruiting participants at 12 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(12)

C.H. d'Angoulême

Angoulême, France

C.H. Victor Dupouy

Argenteuil, France

C.H. de Béthune

Béthune, France

Hôpitaux de Chartres

Chartres, France

C.H.U. de Lille

Lille, France

C.H.U. de Montpellier

Montpellier, France

Hôtel-Dieu - CHU de Nantes

Nantes, France

C.H.U. de Poitiers

Poitiers, France

C.H.U. de Rouen

Rouen, France

C.H.U. de Toulouse

Toulouse, France

C.H. de Tourcoing

Tourcoing, France

C.H. de Valenciennes

Valenciennes, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04199403


Related Trials